P. Thaker Et Al. , "Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors," CLINICAL CANCER RESEARCH , vol.11, no.13, pp.4923-4933, 2005
Thaker, P. Et Al. 2005. Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors. CLINICAL CANCER RESEARCH , vol.11, no.13 , 4923-4933.
Thaker, P., Yazici, S., Nilsson, M., Yokoi, K., Tsan, R., He, J., ... Kim, S.(2005). Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors. CLINICAL CANCER RESEARCH , vol.11, no.13, 4923-4933.
Thaker, PH Et Al. "Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors," CLINICAL CANCER RESEARCH , vol.11, no.13, 4923-4933, 2005
Thaker, PH Et Al. "Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors." CLINICAL CANCER RESEARCH , vol.11, no.13, pp.4923-4933, 2005
Thaker, P. Et Al. (2005) . "Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors." CLINICAL CANCER RESEARCH , vol.11, no.13, pp.4923-4933.
@article{article, author={PH Thaker Et Al. }, title={Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors}, journal={CLINICAL CANCER RESEARCH}, year=2005, pages={4923-4933} }